HRSA Pushes Ahead On 340B Hospital Audits, Gets $6M For Oversight
This article was originally published in The Pink Sheet Daily
The Health Resources and Services Administration is continuing to audit hospitals for 340B compliance, with 94 conducted in FY 2013 and 28 completed or begun thus far in FY 2014, and one manufacturer is being audited as well. A $6 million appropriation will help the agency expand its oversight activities.
You may also be interested in...
Top Republicans on two Senate health committees are joined by House members in seeking answers on an HHS review of entities receiving 340B drug discounts, including the process and consequences of audits and decertification.
In its first year of auditing 340B facilities for compliance with drug discount rules, the HHS agency is investigating 45 randomly selected entities and six “targeted” entities that are the subject of specific allegations of non-compliance. About 250 hospitals have been decertified from 340B and may have to pay back discounts to drug makers.
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.